{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:15:49Z","timestamp":1778620549120,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL139448"],"award-info":[{"award-number":["R01HL139448"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL142122"],"award-info":[{"award-number":["R01HL142122"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL151730"],"award-info":[{"award-number":["R01HL151730"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R35 HL150698"],"award-info":[{"award-number":["R35 HL150698"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL128895"],"award-info":[{"award-number":["HL128895"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jtha.2024.12.015","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T22:07:09Z","timestamp":1735078029000},"page":"1066-1076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-8491","authenticated-orcid":false,"given":"Sooho S.","family":"Myoung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel J.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonah","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubica","family":"Rauova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mortimer","family":"Poncz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Cines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maragatha","family":"Kuchibhatla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0496-5064","authenticated-orcid":false,"given":"Gowthami M.","family":"Arepally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.12.015_bib1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jtha.2022.11.043","article-title":"Modulation of ultralarge immune complexes in heparin-induced thrombocytopenia","volume":"21","author":"Cai","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.015_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally","year":"2020","journal-title":"Transl Res"},{"key":"10.1016\/j.jtha.2024.12.015_bib3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.12.015_bib4","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood-2015-07-660001","article-title":"Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program","volume":"127","author":"McGowan","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib5","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.lab.2005.08.003","article-title":"Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?","volume":"146","author":"Warkentin","year":"2005","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jtha.2024.12.015_bib7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1213\/ANE.0b013e31820b5f39","article-title":"The diagnostic value of the anti-PF4\/heparin immunoassay high-dose heparin confirmatory test in cardiac surgery patients","volume":"112","author":"Selleng","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2024.12.015_bib8","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1538-7836.2007.02617.x","article-title":"Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4\/heparin antibodies of the IgG, IgM, and IgA classes","volume":"5","author":"Greinacher","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.015_bib9","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1538-7836.2004.01039.x","article-title":"Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia","volume":"2","author":"Zwicker","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.015_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-0609.2008.01035.x","article-title":"Higher optical density of an antigen assay predicts thrombosis in patients with heparin-induced thrombocytopenia","volume":"80","author":"Altuntas","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtha.2024.12.015_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjmed.2011.06.025","article-title":"Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels","volume":"125","author":"Baroletti","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2024.12.015_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.thromres.2011.05.003","article-title":"Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4\/heparin enzyme-immunoassay","volume":"128","author":"Althaus","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.12.015_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1538-7836.2005.01698.x","article-title":"No significant improvement in diagnostic specificity of an anti-PF4\/polyanion immunoassay with use of high heparin confirmatory procedure","volume":"4","author":"Warkentin","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.015_bib14","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.015_bib15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.2020008195","article-title":"A\u00a0prospective, blinded study of a PF4-dependent assay for HIT diagnosis","volume":"137","author":"Samuelson","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-induced thrombocytopenia: a focus on thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.12.015_bib17","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.V95.5.1533.005k01_1533_1540","article-title":"Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies","volume":"95","author":"Arepally","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib18","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood.2020009487","article-title":"Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes","volume":"138","author":"Khandelwal","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib19","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/bloodadvances.2019000235","article-title":"Heterogeneity in neutrophil responses to immune complexes","volume":"3","author":"Duarte","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.12.015_bib20","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1055\/s-0038-1660858","article-title":"Novel immunoassay for complement activation by PF4\/heparin complexes","volume":"118","author":"Khandelwal","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.015_bib21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2012-01-407262","article-title":"Dynamic antibody-binding properties in the pathogenesis of HIT","volume":"120","author":"Sachais","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib22","article-title":"Heparin-dependent platelet antibody (serotonin release assay) test","year":"2024"},{"key":"10.1016\/j.jtha.2024.12.015_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.24006","article-title":"The platelet serotonin-release assay","volume":"90","author":"Warkentin","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.12.015_bib24","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1182\/blood.V98.4.1252","article-title":"Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8","volume":"98","author":"Arepally","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib25","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1111\/j.1538-7836.2010.04059.x","article-title":"The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion","volume":"8","author":"Cuker","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.015_bib26","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1111\/jth.15856","article-title":"Minimal role for the alternative pathway in complement activation by HIT immune complexes","volume":"20","author":"Barnes","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.015_bib27","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1182\/blood-2018-03-834598","article-title":"Polyreactive IgM initiates complement activation by PF4\/heparin complexes through the classical pathway","volume":"132","author":"Khandelwal","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1042\/bj1910769","article-title":"The multiple complexes formed by the interaction of platelet factor 4 with heparin","volume":"191","author":"Bock","year":"1980","journal-title":"Biochem J"},{"key":"10.1016\/j.jtha.2024.12.015_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib31","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib32","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1538-7836.2011.04470.x","article-title":"The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies","volume":"9","author":"Lhermusier","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.015_bib33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood-2013-11-539262","article-title":"Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia","volume":"127","author":"Tutwiler","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib34","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2008-04-153288","article-title":"Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion","volume":"112","author":"Xiao","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib35","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fimmu.2017.00592","article-title":"C1 complex: an adaptable proteolytic module for complement and non-complement functions","volume":"8","author":"Lu","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.12.015_bib36","first-page":"605","article-title":"The role of C1, C1-inactivator and C4 in modulating immune precipitation","volume":"60","author":"Schifferli","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jtha.2024.12.015_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1126\/science.165.3891.396","article-title":"Immune adherence by the fourth component of complement","volume":"165","author":"Cooper","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.jtha.2024.12.015_bib38","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4049\/jimmunol.153.6.2729","article-title":"Cooperation between Fc gamma receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokine-primed human eosinophils","volume":"153","author":"van der Bruggen","year":"1994","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2024.12.015_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.624025","article-title":"Complement receptors and their role in leukocyte recruitment and phagocytosis","volume":"9","author":"Vandendriessche","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jtha.2024.12.015_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.12.015_bib41","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood.V89.8.2863","article-title":"C3a and C5a stimulate chemotaxis of human mast cells","volume":"89","author":"Hartmann","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib42","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1084\/jem.181.6.2119","article-title":"C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation","volume":"181","author":"Daffern","year":"1995","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtha.2024.12.015_bib43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4049\/jimmunol.151.1.377","article-title":"Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor","volume":"151","author":"Morgan","year":"1993","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2024.12.015_bib44","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1182\/blood.V83.11.3324.3324","article-title":"C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins","volume":"83","author":"Elsner","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.015_bib45","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1172\/JCI109031","article-title":"Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in\u00a0vitro model of immune vascular damage","volume":"61","author":"Sacks","year":"1978","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.12.015_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11037","article-title":"Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis","volume":"7","author":"Guglietta","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2024.12.015_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.620427","article-title":"Revisiting the coreceptor function of complement receptor type 2 (CR2, CD21); coengagement with the B-cell receptor inhibits the activation, proliferation, and antibody production of human B cells","volume":"12","author":"Kovacs","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.12.015_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100256","article-title":"Complement receptor 3 mediates both sinking phagocytosis and phagocytic cup formation via distinct mechanisms","volume":"296","author":"Walbaum","year":"2021","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.12.015_bib49","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies","volume":"26","author":"Greinacher","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.12.015_bib50","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/eji.1830151003","article-title":"Antibody density on rat red cells determines the rate of activation of the complement component C1","volume":"15","author":"Hughes-Jones","year":"1985","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtha.2024.12.015_bib51","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.V99.4.1230","article-title":"Defining a second epitope for heparin-induced thrombocytopenia\/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody","volume":"99","author":"Li","year":"2002","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624007359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624007359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:27:10Z","timestamp":1778617630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624007359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1538783624007359"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.12.015","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}